Furthermore, even in patients with biopsy-proven NASH (NAS ≥ 5), elevated ALT performed poorly as a biomarker for NASH (AUROC 0.62) [28]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.